Literature DB >> 9502593

A simple dipstick assay for the detection of antibodies to phenolic glycolipid-I of Mycobacterium leprae.

S S Bührer1, H L Smits, G C Gussenhoven, C W van Ingen, P R Klatser.   

Abstract

Among the many reported applications of the detection of antibodies to phenolic glycolipid-I (PGL-I) of Mycobacterium leprae, in particular, the use of seroprevalence as an indicator of the magnitude of the leprosy problem may turn out to be very useful in leprosy control programs. An operational function of serology within the leprosy control services requires a simple test system. We have developed a simple dipstick assay for the detection of antibodies to PGL-I and compared its performance with that of an ELISA. A high degree of agreement (97.2%) was observed between the ELISA and the dipstick assay when tested on 435 sera; the agreement beyond chance (Kappa value) was 0.92. No significant difference was found between the dipstick assay and the ELISA when seropositivity rates obtained in groups of leprosy patients, household contacts, and controls were compared. The interpretation of the dipstick results as positive or negative was unequivocal, as illustrated by the high agreement between different persons reading the test (Kappa values > 0.88). Storage of the only reagents required, the dipsticks and the stabilized detection reagent, up to three weeks under tropical conditions of high temperatures, high humidity, and exposure to light, did not influence the results of the assay. The dipstick assay described here is an easy-to-perform method for the detection of IgM antibodies to PGL-I of M. leprae; it does not require any special equipment and the highly stable reagents make the test robust and suitable for use in tropical countries. An internal control validates the performance of the assay. This dipstick assay may be the method of choice for epidemiologic mapping of leprosy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9502593     DOI: 10.4269/ajtmh.1998.58.133

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  18 in total

Review 1.  Mycobacterium leprae-host-cell interactions and genetic determinants in leprosy: an overview.

Authors:  Roberta Olmo Pinheiro; Jorgenilce de Souza Salles; Euzenir Nunes Sarno; Elizabeth Pereira Sampaio
Journal:  Future Microbiol       Date:  2011-02       Impact factor: 3.165

2.  Enoyl-coenzyme A hydratase and antigen 85B of Mycobacterium habana are specifically recognized by antibodies in sera from leprosy patients.

Authors:  J Serafín-López; M Talavera-Paulin; J C Amador-Molina; M Alvarado-Riverón; M M Vilchis-Landeros; P Méndez-Ortega; M Fafutis-Morris; V Paredes-Cervantes; R López-Santiago; C I León; M I Guerrero; R M Ribas-Aparicio; G Mendoza-Hernández; C Carreño-Martínez; S Estrada-Parra; I Estrada-García
Journal:  Clin Vaccine Immunol       Date:  2011-05-25

3.  Use of rapid dipstick and latex agglutination tests and enzyme-linked immunosorbent assay for serodiagnosis of amebic liver abscess, amebic Colitis, and Entamoeba histolytica Cyst Passage.

Authors:  H Rogier van Doorn; Henk Hofwegen; Rob Koelewijn; Henk Gilis; Ron Peek; Jose C F M Wetsteyn; Perry J J van Genderen; Tony Vervoort; Tom van Gool
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

4.  Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosy.

Authors:  John S Spencer; Hee Jin Kim; William H Wheat; Delphi Chatterjee; Marivic V Balagon; Roland V Cellona; Esterlina V Tan; Robert Gelber; Paul Saunderson; Malcolm S Duthie; Stephen T Reece; William Burman; Robert Belknap; William R Mac Kenzie; Annemieke Geluk; Linda Oskam; Hazel M Dockrell; Patrick J Brennan
Journal:  Clin Vaccine Immunol       Date:  2010-12-22

5.  Use of enzyme-linked immunosorbent assay and dipstick assay for detection of Strongyloides stercoralis infection in humans.

Authors:  H Rogier van Doorn; Rob Koelewijn; Henk Hofwegen; Henk Gilis; Jose C F M Wetsteyn; Pieter J Wismans; Claudine Sarfati; Tony Vervoort; Tom van Gool
Journal:  J Clin Microbiol       Date:  2006-12-06       Impact factor: 5.948

Review 6.  The continuing challenges of leprosy.

Authors:  D M Scollard; L B Adams; T P Gillis; J L Krahenbuhl; R W Truman; D L Williams
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

7.  Rational design and evaluation of a multiepitope chimeric fusion protein with the potential for leprosy diagnosis.

Authors:  Malcolm S Duthie; Marah N Hay; Cecile Z Morales; Lauren Carter; Raodoh Mohamath; Lucia Ito; Luiza K M Oyafuso; Marli I P Manini; Marivic V Balagon; Esterlina V Tan; Paul R Saunderson; Steven G Reed; Darrick Carter
Journal:  Clin Vaccine Immunol       Date:  2009-12-16

8.  Use of protein antigens for early serological diagnosis of leprosy.

Authors:  Malcolm S Duthie; Wakako Goto; Greg C Ireton; Stephen T Reece; Ludimila P V Cardoso; Celina M T Martelli; Mariane M A Stefani; Maria Nakatani; Robson Crusue de Jesus; Eduardo M Netto; Ma V F Balagon; Esterlina Tan; Robert H Gelber; Yumi Maeda; Masahiko Makino; Dan Hoft; Steven G Reed
Journal:  Clin Vaccine Immunol       Date:  2007-09-26

9.  Serology with ML Flow test in health professionals from three different states of Brazil.

Authors:  Karla Lucena Sampaio Calado; Mônica Maria Ferreira Magnanini; Rodrigo Scaliante de Moura; Maria Eugenia Noviski Gallo; Samira Bührer-Sékula; Maria Leide Wand-Del-Rey de Oliveira
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

10.  Selection of antigens and development of prototype tests for point-of-care leprosy diagnosis.

Authors:  Malcolm S Duthie; Greg C Ireton; Ganga V Kanaujia; Wakako Goto; Hong Liang; Ajay Bhatia; Jean Marie Busceti; Murdo Macdonald; Kapil Dev Neupane; Chaman Ranjit; Bishwa Raj Sapkota; Marivic Balagon; Javan Esfandiari; Darrick Carter; Steven G Reed
Journal:  Clin Vaccine Immunol       Date:  2008-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.